Abstract
A series of novel 5,7-diphenylimidazo[1,2-a]pyridine derivatives was designed and synthesized. The in vitro cytotoxic activities of all the target compounds against human colorectal cancer(HT-29), human lung cancer(H460), human gastric cancer(MKN45) and human breast cancer(MDA-MB-231) cell lines were evaluated. The pharmacological results indicated that most of the target compounds showed moderate to excellent activities against the tested cell lines. The most promising compound 4h(0.20, 0.006, 0.08, 0.021 μmol/L) was 2.6, 5.1, 3.6 and 21.9 times more active than EPC2407(0.52, 0.031, 0.29, 0.46 μmol/L) against HT-29, H460, MKN45 and MDA-MB-231 cell lines, respectively.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ma Z. Y., Zhang X. H., Li C. N., Zheng Y. J., Yang G. L., Wang S. K., He Y., Chem. Res. Chinese Universities, 2011, 27(5), 787
Rebecca S., Deepa N., Ahmedin J., CA Cancer J. Clin., 2013, 63, 11
Downing K. H., Nogales E., Curr. Opin. Cell Biol., 1998, 10, 16
Jordan M. A., Wilson L., Nat. Rev. Cancer, 2004, 4, 253
Shailaja K., Henriette G., Karen M., John D., Sanjeeva R., Qiu L., Zhang H., Frederick B., David B., Quan Y., John H., Serge L., Cai S. X., Mol. Cancer Ther., 2004, 3, 1365
Kamran M., Reza K., Alireza F., Ali M., Hamidreza M. M., Med. Chem. Res., 2011, 20, 920
Majid M., Jamshid D., Mohammad R. Z., Alireza F., Biomed. Pharmacother., 2011, 65, 175
Hassan A., Majid M., Seyed R. M., Mohammad R. Z., Alireza F., Arch. Pharm. Res., 2012, 35, 1573
William K., John D., Jiang S. C., Zhang H., Wang Y., Zhao J. H., Jia S. J., John H., Denis L., Richard S., Karen M., David B., Rabindra R., Real D., Charles B., Serge L., Giorgio A., Henriette G., Ben T., Shailaja K., Cai S. X., J. Med. Chem., 2004, 47, 6299
William K., Shailaja K., Jiang S. C., Zhang H., Zhao J. H., Jia S. J., Xu L. F., Candace C. G., Real D., Nancy B., Louis V., Sylvie C., Jennifer D., Giorgio A., Denis L., Serge L., Henriette G., Ben T., John D., Cai S. X., Bioorg. Med. Chem. Lett., 2005, 15, 4745
Wu X. Y., Ma W., Kiran G., Guo C. H., J. Formos. Med. Assoc., 2013, 3, 115
William K., John D., Jiang S. C., Zhang H., Zhao J. H., Candace C. G., Xu L. F., Serge L., Henriette G., Real D., Ben T., Shailaja K., Cai S. X., J. Med. Chem., 2007, 50, 2858
William K., John D., Jiang S. C., Zhang H., Candace C. G., Denis L., Monica B., Giorgio A., Real D., Serge L., Henriette G., Ben T., Shailaja K., Cai S. X., J. Med. Chem., 2008, 51, 417
William K., Jiang S. C., Wang Y., Shailaja K., Candace C. G., Monica B., Denis L., Real D., Serge L., Giorgio A., Henriette G., Ben T., John D., Cai S. X., Bioorg. Med. Chem. Lett., 2008, 18, 603
Cai S. X., John D., William K., Anticancer Agents Med. Chem., 2009, 9, 437
Alan R. K., Xu Y. J., Tu H. B., J. Org. Chem., 2003, 68, 4935
Caroline C., Maxime D. C., Patrice V., Heterocycles, 2005, 65, 2979
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China(No.81273357).
Rights and permissions
About this article
Cite this article
Liao, H., Chong, L., Tan, L. et al. Synthesis and biological evaluation of novel 5,7-diphenylimidazo[1,2-a]pyridine derivatives. Chem. Res. Chin. Univ. 30, 759–763 (2014). https://doi.org/10.1007/s40242-014-4081-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-014-4081-3